Analytical Data
-
基因名
SLC17A5
- Application
-
别名
Sialin; H(+)/nitrate cotransporter; H(+)/sialic acid cotransporter; AST; Membrane glycoprotein HP59; Solute carrier family 17 member 5; Vesicular excitatory amino acid transporter; VEAT; SLC17A5; Homo sapiens; Human; AST
-
种属
Human
-
表达系统
HEK293
-
标签
His;MBP;Flag
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NRA2-1
-
表达区间
R2-H495
-
蛋白长度
Partial
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC17A5, also known as the solute carrier family 17 member 5, encodes a protein primarily involved in the transport of neurotransmitters and other solutes across cellular membranes. This protein is notably linked to the functioning of lysosomal storage, particularly in the context of Salla disease, a genetic condition that arises from mutations in the SLC17A5 gene, leading to the accumulation of sialic acid in the body. Research on SLC17A5 recombinant proteins has gained attention due to their potential implications in understanding the pathophysiology of related disorders and developing therapeutic strategies. The availability of these proteins allows for detailed studies on their structure, function, and interaction with substrates, which is crucial for elucidating their role in cellular processes. Furthermore, SLC17A5's involvement in lysosomal function highlights its significance in the treatment of lysosomal storage diseases, making it a target for gene therapy and drug development. Overall, the study of SLC17A5 recombinant proteins is essential for advancing our knowledge of neurodegenerative conditions and related metabolic disorders, paving the way for innovative solutions to tackle these challenges.
